June 26, 2009 — The American Thoracic Society (ATS) and the European Respiratory Society (ERS) have released official standards regarding asthma evaluation for clinical trials and practice. The joint ...

In asthma management, the latest Global Initiative for Asthma (GINA) guidelines recommend that treatment should be continuously adjusted, driven by the patient’s asthma control status. 1 Although ...

Guidelines recommend basing asthma management on assessment of asthma control. Validated control tools, while suitable for clinical research, may not be feasible for routine use in primary care. A ...

Most patients in the nonomalizumab cohort had moderate asthma according to subjective physician assessment (77%), and the mean (SD) length of time since asthma diagnosis was 21 (17) years (Table 2).

The update includes new focus on monitoring asthma control as the goal for asthma therapy and distinguishing between classifying asthma severity and monitoring asthma control Emphasis is placed on ...

Severe asthma can be difficult to control. You may experience more frequent flare-ups. In some cases, severe asthma may be resistant to conventional treatments typically used for mild to moderate ...

The American Thoracic Society and the European Respiratory Society have released official standards for clinical trials and practice with respect to the assessment of asthma. The statement appears in ...

LONDON--(BUSINESS WIRE)--NuvoAir’s Asthma Assessment Service uses respiratory physiologists and connected, award-winning home monitoring technology, such as the Air Next spirometer to assess lung ...

Among children, asthma is the most common chronic disease, ranking among the top 20 conditions worldwide for disability-adjusted life years in children. It is diagnosed through a procedure called ...

Acute exacerbations in chronic obstructive pulmonarydisease (COPD) and asthma are potentiallylife-threatening clinical events that may result insubstantial morbidity and mortality. Treatment ofthese ...

"Asthma Pipeline Insights"DelveInsight's,“Asthma - Pipeline Insight, 2025,” report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Asthma pipeline landscape. It covers ...